Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma giants slam 'appalling' postcode lottery for weight loss drugs
Global pharmaceutical giants stepped up pressure on the Albanese government to subsidise weight-loss drugs, releasing data showing people in Sydney's west and regional areas are 34 per cent less likely to buy the medicines than affluent city…
Eastern Bank Acquires 263,867 Shares of Royalty Pharma PLC $RPRX
Eastern Bank lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 71.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 635,122 shares of…
From lab to global markets: HKSTP leads Hong Kong's rise as a biotech powerhouse
Many cancer patients receiving chemotherapy worldwide face complications driven by drug resistance. Hong Kong–based latestage oncology biopharma Health Hope Pharma (HHP) focuses on novel oral anticancer therapies that offer a safer, more…
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico's CEO, Alex Zhavoronkov, said Eli Lilly has a competitive edge in certain…
Eli Lilly Links to ESPN's Pat Summitt Reunion Special, Seeking New Ways to Tell Medical Stories
Eli Lilly & Co. hopes its sponsorship of an event tied to the heroic coach Pat Summitt will do just as much for the company as the many commercials it runs each year. When “Celebrating Pat Summitt: Live Reunion Special,” airs on ESPN2…
Eli Lilly leans into AI drug discovery with new licensing deal
US pharmaceutical giant Eli Lilly inked a $2.75 billion deal with a Hong Kong-listed biotech firm to create new medicines using AI. Insilico Medicine, which develops drugs in China and went public in December, says it has produced at least 28…
1 Reason This Biotech Stock Could Triple Before Year-End
When you think of GLP-1s and investing, the two large pharmaceutical companies benefiting most from this trend may first come to mind. First, there's Novo Nordisk, the first to bring GLP-1 weight loss drugs to market, with Ozempic and Wegovy.
Crude oil shock deepens market jitters as Hormuz crisis hits India's macro outlook
Equity markets are grappling with a deepening correction as a geopolitical shock in West Asia morphs into a full-blown oil-driven macro risk. What began as a sentiment-led sell-off has now evolved into a tangible supply disruption, with tanker…
CPAC 2026: NIH Jay Bhattacharya: 'It's No Longer Tony Fauci's NIH
Director of the National Institutes of Health (NIH) and Acting Director of the Centers for Disease Control and Prevention (CDC) Jay Bhattacharya took to the CPAC stage to declare, 'It's no longer Tony Fauci's NIH.' Dr. Bhattacharya's remarks…
Blackstone-backed EPL, Indovida to merge to create $2 bn packaging firm
Blackstone-backed packaging firm EPL Ltd and Indorama Ventures' Indovida India, have signed definitive agreements to merge, in a deal that will create a $1-billion revenue consumer packaging platform focused on emerging markets, with a combined…
CPAC 2026: HHS Secretary Robert F. Kennedy Jr. Talks the MAHA Agenda One Year In
Health and Human Services Secretary Robert Kennedy Jr. was greeted by cheers and ovations as he closed out CPAC 2026. As one of the most popular Cabinet officials, he offered insight into what a year of initiatives and programs geared to Make…
10 Best Single-Season Shows That Only Got Better Over Time
Some shows are only one season by design, like the masterful four episodes of Adolescence that were each filmed in one shot. Others were tragically short-lived, like B.J. Novak's The Premise, a high-concept anthology that was canceled after only…
Dr. Betsy Eads: CV19 Vax Causes EXPLOSION IN CANCER
JAB INJURIES: GROSS CALAMARI BLOOD CLOTS/AUTISM TSUNAMI/SADS/TURBO CANCER/BIZARRE TERMINAL ILLNESSES: More tragic victims of the ruling parasite genocidal enslavement agenda, sacrificed on the altar of psychopathic greed and hatred of humanity. It…
Eli Lilly and Company $LLY Shares Acquired by World Investment Advisors
World Investment Advisors increased its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 17.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned…
Synergy Asset Management LLC Sells 50,043 Shares of Eli Lilly and Company $LLY
Synergy Asset Management LLC cut its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 92.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm…
Receive a Daily briefing on Pharma Industry News
Get Started